{
    "2019-06-14": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Bluebird Bio prices gene therapy at nearly $1.8m",
                "features": {
                    "keywords": [
                        "Bluebird",
                        "Bio",
                        "prices",
                        "gene",
                        "therapy",
                        "$1.8m"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Roche Reports Positive Data on Rituxan for Pemphigus Vulgaris",
                "features": {
                    "keywords": [
                        "Roche",
                        "Reports",
                        "Positive",
                        "Data",
                        "Rituxan",
                        "Pemphigus",
                        "Vulgaris"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}